Utah Medical Products, Inc. (NASDAQ:UTMD) Director Ernst G. Hoyer sold 5,212 shares of the firm’s stock in a transaction dated Thursday, February 15th. The shares were sold at an average price of $89.11, for a total value of $464,441.32. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Shares of Utah Medical Products, Inc. (UTMD) opened at $90.80 on Friday. Utah Medical Products, Inc. has a twelve month low of $58.50 and a twelve month high of $94.00. The stock has a market capitalization of $323.69, a P/E ratio of 39.65 and a beta of 0.77.
Utah Medical Products (NASDAQ:UTMD) last posted its quarterly earnings data on Tuesday, January 30th. The medical instruments supplier reported $0.95 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 18.92% and a net margin of 20.54%. The company had revenue of $10.20 million for the quarter.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 3rd. Shareholders of record on Friday, March 16th will be issued a dividend of $0.27 per share. The ex-dividend date of this dividend is Thursday, March 15th. This represents a $1.08 annualized dividend and a yield of 1.19%. Utah Medical Products’s dividend payout ratio is presently 47.16%.
Hedge funds have recently bought and sold shares of the business. Acadian Asset Management LLC purchased a new stake in Utah Medical Products during the 4th quarter worth approximately $130,000. MetLife Investment Advisors LLC purchased a new stake in Utah Medical Products during the 4th quarter worth approximately $163,000. SG Americas Securities LLC purchased a new stake in Utah Medical Products during the 4th quarter worth approximately $189,000. The Manufacturers Life Insurance Company increased its holdings in Utah Medical Products by 15.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,355 shares of the medical instruments supplier’s stock worth $242,000 after purchasing an additional 448 shares during the last quarter. Finally, OxFORD Asset Management LLP purchased a new stake in Utah Medical Products during the 2nd quarter worth approximately $267,000. Institutional investors own 66.39% of the company’s stock.
Separately, BidaskClub upgraded Utah Medical Products from a “hold” rating to a “buy” rating in a report on Wednesday, February 7th.
COPYRIGHT VIOLATION WARNING: This article was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another domain, it was copied illegally and reposted in violation of international copyright and trademark law. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2018/02/17/ernst-g-hoyer-sells-5212-shares-of-utah-medical-products-inc-utmd-stock.html.
Utah Medical Products Company Profile
Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.